Buckley Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.1M | Sell |
16,289
-90
| -0.5% | -$19.4K | 1.01% | 19 |
|
|
2026
Q1 | $3.56M | Buy |
16,379
+231
| +1% | +$51.2K | 0.91% | 20 |
|
|
2025
Q4 | $3.69M | Sell |
16,148
-111
| -0.7% | -$25.3K | 0.98% | 20 |
|
|
2025
Q3 | $3.76M | Sell |
16,259
-96
| -0.6% | -$19.5K | 1.03% | 21 |
|
|
2025
Q2 | $3.04M | Sell |
16,355
-60
| -0.4% | -$11.2K | 0.91% | 23 |
|
|
2025
Q1 | $3.44M | Buy |
16,415
+33
| +0.2% | +$6.42K | 1.07% | 21 |
|
|
2024
Q4 | $2.91M | Sell |
16,382
-120
| -0.7% | -$22.1K | 0.89% | 22 |
|
|
2024
Q3 | $3.26M | Buy |
16,502
+148
| +0.9% | +$27.6K | 1% | 22 |
|
|
2024
Q2 | $2.81M | Buy |
16,354
+275
| +2% | +$45.6K | 0.89% | 23 |
|
|
2024
Q1 | $2.93M | Sell |
16,079
-178
| -1% | -$30.7K | 0.94% | 24 |
|
|
2023
Q4 | $2.52M | Sell |
16,257
-45
| -0.3% | -$6.56K | 0.87% | 22 |
|
|
2023
Q3 | $2.43M | Buy |
16,302
+193
| +1% | +$28.3K | 0.91% | 23 |
|
|
2023
Q2 | $2.17M | Sell |
16,109
-3,414
| -17% | -$501K | 0.74% | 27 |
|
|
2023
Q1 | $3.11M | Sell |
19,523
-1,155
| -6% | -$177K | 1.15% | 23 |
|
|
2022
Q4 | $3.34M | Sell |
20,678
-1,176
| -5% | -$180K | 1.22% | 22 |
|
|
2022
Q3 | $2.93M | Sell |
21,854
-1,141
| -5% | -$164K | 1.08% | 25 |
|
|
2022
Q2 | $3.52M | Buy |
22,995
+4,021
| +21% | +$614K | 1.13% | 24 |
|
|
2022
Q1 | $3.08M | Buy |
18,974
+556
| +3% | +$80.8K | 0.83% | 28 |
|
|
2021
Q4 | $2.49M | Buy |
18,418
+984
| +6% | +$116K | 0.73% | 28 |
|
|
2021
Q3 | $1.88M | Buy |
17,434
+894
| +5% | +$102K | 0.61% | 32 |
|
|
2021
Q2 | $1.86M | Buy |
16,540
+283
| +2% | +$31.9K | 0.64% | 28 |
|
|
2021
Q1 | $1.76M | Buy |
16,257
+961
| +6% | +$103K | 0.65% | 28 |
|
|
2020
Q4 | $1.64M | Buy |
15,296
+888
| +6% | +$85.3K | 0.67% | 27 |
|
|
2020
Q3 | $1.26M | Buy |
14,408
+514
| +4% | +$48.4K | 0.57% | 28 |
|
|
2020
Q2 | $1.36M | Buy |
13,894
+719
| +5% | +$63.3K | 0.62% | 30 |
|
|
2020
Q1 | $1M | Buy |
13,175
+5,115
| +63% | +$436K | 0.54% | 32 |
|
|
2019
Q4 | $714K | Hold |
8,060
| – | – | 0.32% | 56 |
|
|
2019
Q3 | $610K | Buy |
8,060
+1,826
| +29% | +$125K | 0.3% | 63 |
|
|
2019
Q2 | $453K | Buy |
6,234
+420
| +7% | +$33K | 0.21% | 91 |
|
|
2019
Q1 | $469K | Hold |
5,814
| – | – | 0.22% | 92 |
|
|
2018
Q4 | $536K | Hold |
5,814
| – | – | 0.28% | 76 |
|
|
2018
Q3 | $550K | Sell |
5,814
-96
| -2% | -$9.1K | 0.24% | 87 |
|
|
2018
Q2 | $548K | Sell |
5,910
-973
| -14% | -$95K | 0.26% | 85 |
|
|
2018
Q1 | $651K | Sell |
6,883
-287
| -4% | -$31.5K | 0.32% | 73 |
|
|
2017
Q4 | $693K | Buy |
+7,170
| New | +$676K | 0.35% | 64 |
|
Other funds holding ABBV
Buckley Wealth Management's ABBV Position: Q2 2026 in Review
Buckley Wealth Management reduced its AbbVie (ABBV) stake by 0.55% in Q2 2026, selling an estimated $19.4K and leaving 16,289 shares worth $4.1M. The position accounts for 1.01% of the portfolio, ranked #19.
Buckley Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Buckley Wealth Management held 16,289 shares of AbbVie worth $4.1M as of Q2 2026.
- Buckley Wealth Management sold 90 AbbVie shares in Q2 2026, an estimated $19.4K.
- AbbVie made up 1.01% of Buckley Wealth Management's portfolio in Q2 2026, its #19 holding.
- Buckley Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Buckley Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.